Found 4 matching trials
A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies
PHASE1This is a phase I study of a novel compound P1446A-05. Aim of this study is...
Location
Tom Baker Cancer Centre
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
PHASE1This is an open-label, Phase I/Ib trial with a dose escalation phase, follo...
Location
Dana-Farber Cancer Institute
A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies
PHASE1This is a phase I open label study to evaluate safety and efficacy of P1446...
Location
Tata Memorial Centre
Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation
PHASE1* An Open Label, Multicenter, Phase I Extension Study of an Oral Cdk Inhibi...
Location
UCSF Medical Center at Mount Zion